Close
Back to GTHX Stock Lookup

(GTHX) – Hot FDA News

Feb 13, 2023 06:01 AM G1 Therapeutics (GTHX) Reports Top Line Results from Phase 3 Trial of Trilaciclib
Feb 16, 2021 06:23 AM G1 Therapeutics (GTHX) Announces FDA Approves its COSELA: The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
Apr 29, 2019 04:54 PM
Nov 26, 2018 04:03 PM

Back to GTHX Stock Lookup